Regulation of corticosteroid binding globulin (CBG) in the inflammatory context of cystic fibrosis

J. Taytard, C. Rebeyrol, D. Debray, A. Clement, N. Chignard, P. Le Rouzic (Paris, France)

Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Session: Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Session type: Oral Presentation
Number: 366
Disease area: Airway diseases

Congress or journal article abstractE-posterSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Taytard, C. Rebeyrol, D. Debray, A. Clement, N. Chignard, P. Le Rouzic (Paris, France). Regulation of corticosteroid binding globulin (CBG) in the inflammatory context of cystic fibrosis. Eur Respir J 2011; 38: Suppl. 55, 366

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oral contraceptives do not appear to affect cystic fibrosis disease severity
Source: Eur Respir J 2013; 41: 67-73
Year: 2013



Relation of serum IGF-1 and IGFBP3 levels with acute exacerbation in cystic fibrosis
Source: International Congress 2018 – Clinical problems in paediatric pulmonology
Year: 2018

Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis
Source: Eur Respir J 2008; 31: 36-42
Year: 2008



Serum microRNA levels in paediatric females versus males with cystic fibrosis
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Inflammatory response upon viral infection in cystic fibrosis airway epithelial cells
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010

Supressive antimicrobial therapy in chronic bronchial infection: the example of cystic fibrosis
Source: Annual Congress 2011 - Chronic bronchial infection: more than a syndrome
Year: 2011

Tolerance and efficacy of slow release octreotide in idiopathic pulmonary fibrosis. The FIBROSAND study
Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis
Year: 2010

Relationships between bronchodilator therapy, resting energy expenditure and systemic inflammation in cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 503s
Year: 2003

Circulating inflammatory cytokines in adult cystic fibrosis patients
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009

Anti-fibrotic role of inhaled interferon-γ in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis
Source: Annual Congress 2005 - Progresses in lung fibrosis
Year: 2005


Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Plasma protein signature of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016

The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013

E-cadherin (CDH-1) polymorphisms associate with airway remodeling, inflammation and FEV1 decline in asthma patients using inhaled corticosteroids (ICS)
Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases
Year: 2010

Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma
Source: Eur Respir J, 54 (5) 1900068; 10.1183/13993003.00068-2019
Year: 2019



Airway bacterial colonization is associated with low vitamin D serum levels in children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013